相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure
Wouter C. Meijers et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Relationship Between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis From HF-ACTION
Mona Fiuzat et al.
JOURNAL OF CARDIAC FAILURE (2014)
Investigational drugs targeting cardiac fibrosis
Francois Roubille et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2014)
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Laurent Calvier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
Thomas G. von Lueder et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure Data From CORONA and COACH
A. Rogier van der Velde et al.
CIRCULATION-HEART FAILURE (2013)
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure
Dirk J. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
Galectin-3 in heart failure with preserved ejection fraction
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction
Francisco Javier Carrasco-Sanchez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
A review of current therapies used in the treatment of congestive heart failure
Raj Parikh et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2013)
Galectin-3 in Ambulatory Patients With Heart Failure Results From the HF-ACTION Study
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2012)
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Lars Gullestad et al.
EUROPEAN HEART JOURNAL (2012)
Why do drugs for acute heart failure fail?
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
The fibrosis marker galectin-3 and outcome in the general population
R. A. de Boer et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Personalizing biomarker strategies in heart failure with galectin-3
Nasser Sherwi et al.
FUTURE CARDIOLOGY (2012)
Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival
W. H. Wilson Tang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Galectin-3-A jack-of-all-trades in cancer
Anna U. Newlaczyl et al.
CANCER LETTERS (2011)
Galectin-3 in heart failure: high levels are associated with all-cause mortality
Thor Ueland et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
Ajay M. Shah et al.
LANCET (2011)
Epidemiology and risk profile of heart failure
Anh L. Bui et al.
NATURE REVIEWS CARDIOLOGY (2011)
Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
Maria Kolatsi-Joannou et al.
PLOS ONE (2011)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
Ravi V. Shah et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Myocardial remodeling after infarction: the role of myofibroblasts
Susanne W. M. van den Borne et al.
NATURE REVIEWS CARDIOLOGY (2010)
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
Yun-He Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
The immunological potential of galectin-1 and-3
Amy Dhirapong et al.
AUTOIMMUNITY REVIEWS (2009)
Galectin-3: a novel mediator of heart failure development and progression
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
The regulation of inflammation by galectin-3
Neil C. Henderson et al.
IMMUNOLOGICAL REVIEWS (2009)
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
Neil C. Henderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources
U. V. Sathisha et al.
GLYCOCONJUGATE JOURNAL (2007)
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
Roland R. van Kimmenade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs
OV Glinskii et al.
NEOPLASIA (2005)
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes
N Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
Why do phase III trials of promising heart failure drugs often fail? The contribution of 'regression to the truth
H Krum et al.
JOURNAL OF CARDIAC FAILURE (2003)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
GA Rabinovich et al.
TRENDS IN IMMUNOLOGY (2002)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
分享论文
